Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

20.94
-0.8800-4.03%
Post-market: 21.030.0900+0.43%19:30 EDT
Volume:1.93M
Turnover:40.70M
Market Cap:4.07B
PE:-41.82
High:22.27
Open:21.66
Low:20.79
Close:21.82
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:0.82
T/O Rate:2.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.31
PE(LYR):-12.93

Loading ...

Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?

Simply Wall St.
·
Aug 19

Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda

TIPRANKS
·
Aug 19

Legend Biotech Seeks Shareholder OK to Add 19.1 Million Shares to RSU Plan Reserve

Reuters
·
Aug 19

Legend Biotech Announces Annual General Meeting

Reuters
·
Aug 19

How Legend Biotech’s Q2 Profitability Jump and Interim CEO Shift Will Impact Legend Biotech (LEGN) Investors

Simply Wall St.
·
Aug 18

Legend Biotech price target lowered to $78 from $80 at Barclays

TIPRANKS
·
Aug 17

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

CorMedix Beats Q2 Revenue Estimates on DefenCath Growth, Raises FY Adjusted Ebitda Guidance

Reuters
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

MaxCyte Q2 Revenue Beats Estimates

Reuters
·
Aug 13

Kura Oncology Q2 Product Revenue Rises 57% on Komzifti Uptake

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13

Legend Biotech Shares Fall After Oppenheimer Downgrade

MT Newswires Live
·
Aug 13

Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says

MT Newswires Live
·
Aug 12

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

MT Newswires Live
·
Aug 12

Legend Biotech Price Target Cut to $58.00/Share from $59.00 by RBC Capital

Dow Jones
·
Aug 12

Legend Biotech Corp. : Oppenheimer Cuts to Perform from Outperform

THOMSON REUTERS
·
Aug 12

Goldman Sachs Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

MT Newswires Live
·
Aug 12